Drugs

Rasburicase (1)

Pharmacogenomic Information
  

Drug Therapeutic Area*
Biomarker†
Referenced
Subgroup
Labeling Sections
Rasburicase Oncology G6PD G6PD deficient Boxed Warning,
Contraindications,
Warnings and Precautions

 

* Therapeutic areas do not necessarily reflect the CDER review division.
 
 
 
† Standard nomenclature is used for genes as per the Human Genome Organization symbol, cytogenetic abnormalities as per the International System for Human Cytogenetic Nomenclature, or other conventions.

 

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling

Page Last Updated: 04/27/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.